Increased endothelial expression of HLA-DQ and interleukin 1α in extra-articular Rheumatoid Arthritis. Results from immunohistochemical studies of skeletal muscle

Revmatologiia

Volumn 40, Issue 12, 2001, Pages 1346-1354

  Turesson, C ^a   Englund, P ^b   Jacobsson, L T H ^a   Sturfelt, G ^a   Truedsson, L ^a   Nennesmo, I ^b   Lundberg, I E ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; Endothelial activation; Extra articular manifestations; HLA DQ; Interleukin 1 ; Rheumatoid arthritis; Vasculitis

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; HLA DQ ANTIGEN; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CAPILLARY; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; ENDOTHELIUM CELL; FEMALE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MALE; MICROSCOPY; MORTALITY; MUSCLE BIOPSY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; VASCULAR ENDOTHELIUM; VASTUS LATERALIS MUSCLE;

EID: 0035688412     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kirk J, Cosh J. The pericarditis of rheumatoid arthritis Q J Med 1969;37:397-423.
2. Geirsson A, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 1987; 46:727-33.
3. Turesson C, Jacobsson L, Bergström U. Prevalence and mortality of extraarticular rheumatoid arthritis. Rheumatology 1999;38:668-74.
4. Roubenoff R, Roubenoff RA, Cannon JG et al. Rheumatoid cachexia: cytokine driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86.
5. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953; 249:553-6.
6. Wolfe F, Mitchell DM, Sibley JT et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
7. Jacobsson LTH, Knowler WC, Pillemer S et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993;36:1045-53.
8. Wållberg-Jonsson S, Öhman M-L, Rantapää-Dahlqvist S. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis in northern Sweden. J Rheumatol 1997;24:445-51.
9. Foster AC, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmoloey 1984;91:1253-63.
10. Vollertsen RS, Conn DL, Ballard DJ, Ilstrup DM, Kazmar RE, Silverfield JC. Rheumatoid vasculitis: survival and associated risk factors. Medicine 1986;65:365-75.
11. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extra-articular disease manifestations is associated with excess mortality in a population based cohort of patients with rheumatoid arthritis. Arthritis Rheum 2000;43:S385.
12. Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 1997;36:164-9.
13. Coll-Vincent B, Grau JM, López-Soto A et al. Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Br J Rheumatol 1997;36:1178-83.
14. Denton CP, Bickerstaff MCM, Shiwen X et al. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol 1995;34:1048-54.
15. Voskuyl AE, Martin S, Melchers I, Zwinderman AH, Weichselbraun I, Breedveld FC. Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leukocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol 1995;34:311-5.
16. Ridker PM, Hennekens CH, Roitman-Johnson B, Strampfer MJ, Allen J. Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
17. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med 2000;342:836-43.
18. Lundberg I, Ulfgren A-K, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997;40:865-74.
19. Sokoloff L, Wilens SL, Bunim JJ. Arteritis of striated muscle in rheumatoid arthritis. Am J Pathol 1951;27: 157-73.
20. Kraus A, Palacios A, Munoz L. Muscular involvement in systemic rheumatoid vasculitis. Br J Rheumatol 1992; 31:355-8.
21. Voskuyl AE, van Duinen SG, Zwinderman AH, Breedveld FC, Hazes JMW. The diagnostic value of perivascular infiltrates in muscle biopsy specimen for the assessment of rheumatoid vasculitis. Ann Rheum Dis 1998;57:114-7.
22. Verschueren PC, Voskuyl AE, Smeets TJ, Zwinderman KH, Breedveld FC, Tak PP. Increased cellularity and expression of adhesion molecules in muscle biopsy specimen from patients with rheumatoid arthritis with clinical suspicion of vasculitis, but negative routine histology. Ann Rheum Dis 2000;59:598-606.
23. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Henriksson KG. 'Semi-open' muscle biopsy technique. A simple outpatient procedure. Acta Neurol Scand 1979; 59:317-23.
25. Frostegård J, Ulfgren A-K, Nyberg P et al. Cytokine expression in advanced human atherosclerotic plaques: Dominance of proinflammatory (Th1) and macrophagestimulating cytokines. Atherosclerosis 1999; 145:33-43.
26. Nyberg P, Wikman A-L, Nennesmo I, Lundberg I. Increased expression of interleukin-1α and MHC class I in muscle tissue of patients with chronic inactive polymyositis and dermatomyositis. J Rheumatol 2000;27:940-8.
27. Truedsson L, Sjöholm AG, Sturfelt G. Complement activating rheumatoid factors in rheumatoid arthritis studied by hemolysis in gel: relation to antibody class and response to treatment with podophyllotoxin derivatives. Clin Exp Rheumatol 1985;3:29-37.
28. Lundberg I, Kratz A-K, Alexandersson H, Patarroyo M. Decreased expression of interleukin-1α, interleukin-1β and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum 2000;42:336-48.
29. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397-440.
30. Paleolog EM, Elliott MJ, Feldmann M, Maini RN, Woody JN. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor a antibody in rheumatoid arthritis. Arthritis Rheum 1996;39:1082-91.
31. Moreland LW, Baumgartner SW, Schiff MH et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Eng J Med 1997;337:141-7.
32. Maini RN, Breedveld FC, Kalden JR et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
33. Deleuran BW, Chu CQ, Field M et al. Localization of interleukin-la, type 1 interleukin receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 1992;31:801-9.
34. Barkley D, Allard S, Feldmann M, Maini RN. Increased expression of HLA-DQ antigens by interstitial cells and endothelium in the synovial membrane of rheumatoid arthritis patients compared with reactive arthritis patients. Arthritis Rheum 1989;32:955-63.
35. Klareskog L, Johnell O, Hulth A. Expression of HLA-DR and HLA-DQ antigens on cells within the cartilage-pannus junction in rheumatoid arthritis. Rheumatol Int 1984;4:11-5.
36. Hillarby MC, Clarkson R, Grennan DM et al. Immunogenetic heterogeneity in rheumatoid disease as illustrated by different MHC associations (DQ, Dw and C4) in articular and extra-articular subsets Br J Rheumatol 1991;30:5-9.
37. Turesson C, Jacobsson L, Bergström U, Truedsson L, Sturfelt G. Predictors of extra-articular rheumatoid arthritis. Scand J Rheumatol 2000;29:358-64.
38. Pober JS. Cytokine mediated activation of vascular endothelium. Am J Pathol 1988; 133:426-33.
39. Brody JI, Pickering NJ, Capuzzi DM, Fink GB, Can CA, Gomez F. Interleukin-1 as a factor in occlusive vascular disease. Am J Clin Pathol 1992;97:8-13.
40. Dejana E, Brevario F, Erroi A et al. Modulation of endothelial cell functions by different molecular species of interleukin-1. Blood 1987;69:695-9.
41. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of MHC class II antigens in normal human organs. Transplantation 1984; 38:293-8.
42. Bürrig K-F. The endothelium of advanced arteriosclerotic plaques in humans. Art Thromb 1991;11:1678-89.